7 Analysts Have This to Say About Amylyx Pharma
Portfolio Pulse from Benzinga Insights
Amylyx Pharma (NASDAQ:AMLX) has received 6 bullish and 1 indifferent analyst ratings in the last quarter, with an average 12-month price target of $50.43, up 5.06% from the previous average of $48.00.
May 31, 2023 | 1:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amylyx Pharma has 6 bullish and 1 indifferent analyst ratings, with an average 12-month price target of $50.43, up 5.06% from the previous average.
The majority of analysts have a bullish outlook on Amylyx Pharma, with 6 out of 7 giving positive ratings. The average 12-month price target has increased by 5.06% from the previous average, indicating a positive sentiment towards the stock. This is likely to result in a short-term upward price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100